Clearmind Medicine Inc. Common Shares
Symbol: CMND (NASDAQ)
1.11
▲ (10.50%) 0.105
Company Description:
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Key Stats
- Today's Open: $1.21
- Today's High: $1.419
- Today's Low: $1.007
- Today's Volume: 37.59M
- Yesterday Close: $1
- Yesterday High: $1.03
- Yesterday Low: $0.998
- Yesterday Volume: 37.01K
- Last Min Volume: 1.94K
- Last Min High: $1.105
- Last Min Low: $1.105
- Last Min VWAP: $1.105
Company Profile
- Name: Clearmind Medicine Inc. Common Shares
- Website: https://www.clearmindmedicine.com
- Listed Date: 2021-08-10
- Location: ,
- Market Status: Active
- CIK Number: 0001892500
- SIC Code:
- SIC description:
- Market Cap: $5.38M
- Round Lot: 100
- Outstanding Shares: 5.38M
- Asset Type: CS
RECENT FILINGS FOR CMND
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | F-1 | View |
| 2025-09-19 | 6-K | View |
| 2025-09-17 | 6-K | View |
| 2025-09-15 | POS AM | View |
| 2025-09-11 | 6-K | View |
| 2025-08-07 | 6-K | View |
| 2025-08-05 | 6-K | View |
| 2025-07-30 | 6-K | View |
| 2025-07-29 | 6-K | View |
| 2025-07-15 | 6-K | View |
| 2025-07-03 | SCHEDULE 13G/A | View |
| 2025-07-03 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-27 | 6-K | View |
| 2025-06-23 | 6-K | View |
| 2025-06-18 | EFFECT | View |
| 2025-06-12 | POS AM | View |
| 2025-06-12 | 6-K | View |
| 2025-06-12 | 6-K | View |
| 2025-06-05 | 6-K | View |
Latest News on CMND